Redirect Notice

Looks like you clickedhttp://www.prnewswire.com/news-releases/imbruvica-ibrutinib-approved-by-us-fda-for-the-first-line-treatment-of-chronic-lymphocytic-leukemia-300231107.html

If you do not want to visit that page, you can close this browser tab.